FDA Approved: FIRAZYR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FIRAZYR (icatibant acetate) by Takeda Pharmaceuticals America, Inc., approving a supplement to the original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Firazyr (icatibant)

Snippet

SUPPL AP for FIRAZYR (ICATIBANT ACETATE)